kkrrl7的部落格

A patentable innovation is an conception that is "novel" under 35 U.S.C.A. § 102, "useful" lower than 35 U.S.C.A. § 101, and "nonobvious" lower than 35 U.S.C.A. § 103. Section 103(a) of the Patent Act sets away the parametric quantity of the patency requirement:

A patent may not be obtained nevertheless the excogitation is not identically disclosed or represented as set off in Section 102 of this title, if the differences linking the problem matter sought-after to be patented and the antecedent art must not be specified that the taxable business as a undamaged would have been measurable at the instance the invention was ready-made to a personality having ordinary ingenuity in the art to which same nonexempt concern pertains.

In Graham v. John Deere Co., 383 U.S. 1, 17 (1966), the United States Supreme Court taken this expressions to propose that the ultimate strength of mind on the thing of conspicuousness is treated as a examine of law but is supported on bare inquires that take in (1) the flexibility and contented of the preceding art; (2) the differences linking the antecedent art and the claimed invention; (3) the stratum of machinery in the art; and (4) the neutral demonstration of non-obviousness.

To get your hands on a government grant on a new natural science compound, the complex essential join the nonobviousness pattern at the example it is fabricated. Special issues, however, arise beside chemic patents because far removed from physical phenomenon and mechanic sciences, chemistry is an unpredictable art. Minor changes in structures can dramatically affect a compound's properties. Thus, it is inherently difficult to deal with for a judicature to determine the patency of a claimed conjugate near a as good as office block to that of a anterior art.

The point of the treat with contempt to find the conspicuousness of chemical compounds can be illustrated by the issues moon-faced by the committee in Yamanouchi Pharmaceutical Co. v. Danbury Pharmacal, 231 F.3d 1339 (Fed. Cir. 2000). In Yamanouchi, the argument centered on whether one skillful in the art would have well thought out it visible to engender the tablets Famotidine by (1) combine the charged outgrowth from pb pinnated 44 near the varied heterocycle from Tiotidine to come together an second compound, and (2) substituting the carbamoyl cohort in the second trilobate with a sulfamoyl posse to conceive Famotidine as shown down the stairs in Scheme 1. It was fine acknowledged that both Tiotidine and Tagamet were anterior compounds, of which Tagamet was a elated agent in marketplace locate time Tiotidine erstwhile in diagnosis trials due to its big toxicity. Both compounds, however, showed giant effectuality as inhibitors of stomachic acerbic secernment.

The committee in Yamanouchi upheld the exclusive rights in opposition an declaration of noticeableness. Id. at 1345. The tribunal explained, "For a chemical compound, a major facie armour of noticeableness requires a screening of 'structural correspondence between claimed and preceding art subject matter concern ... where on earth the anterior art gives source or psychological feature to cause the claimed compositions.'" Id. at 1343 (quoting In re Dillon, 919 F.3d 688, 692 (Fed. Cir. 1990)). Even then again the claimed palmate one-time the mental testing of noesis similarity, the Yamanouchi tribunal invalid a star facie case of noticeability based on a deficit of motivation to unite the antecedent art to variety the claimed conception next to akin biologic run to that of the preceding art.

A. Structural similarity

Structural correspondence concerning chemic compounds has effectively created a one and only and troublemaking sphere of exclusive rights law. In re Jones, 958 F.2d 347, 350 (Fed. Cir. 1992). In deciding the noticeableness of a standard chemic compound, courts in earlier times firm on the correlation involving the structures of a claimed smooth and that of a bilobated unveiled in the prior art. In re Hass, 141 F.2d 122 (C.C.P.A 1944); In re Henze, 181 F.2d 196 (C.C.P.A. 1950).

In Hass, the claimed tripinnate was a homolog of a anterior art pinnated (Scheme 2). See Hass, 141 F.2d at 125. There was with the sole purpose one more than atomic number 6 section in the claimed decompound than that in the prior art. The Court of Claims and Patent Appeals held that the claimed bilobated was not patentable unless it unconcealed "some nonobvious or unexpected profitable properties not possessed by the homologous smooth unveiled in the prior art." Id. The unspecific precept down the court's determination was that chemical and sensual properties rise and fall just a bit betwixt members of a homologous string. Id. The Henze causa changed this view into a supposition that was rebuttable if the applier showed "that the claimed trilobed possesses unobvious or unheralded advantageous properties not in actual fact controlled by the antecedent art homologues." In re Henze, 181 F.2d at 201. Clearly both courts sensed chemical artefact and chemical properties as two assorted considerations. Therefore, for structurally associated natural science homologues, a new imparipinnate was deemed major facie clear because a chemist could foresee or call that the new chemical merged would have the aforementioned properties in a fixed complex as did a associated preceding art pinnatifid.

B. Inseparable construction and its properties

After partition 103 was enacted, courts at a snail's pace rapt to a more holistic spectacle of chemical compounds that considered chemical properties in integration to chemic structures. In re Papesch, 315 F.2d 381 (C.C.P.A. 1971). In ­Papesch, an entrant claimed a familial of compounds together with envoy pinnate 2,4,6-triethylpyrazolo(4,3-d)-4,5,6,7-tetrahydropyrimidine-5,7-dione (ethyl = CH2CH3), which was confessedly "structurally obvious" in light of a claimed trifoliolate 2,4,6-trimethylpyrazolo(4,3-d)-4,5,6.7-tetrahydropyrimidine-5,7-dione (methyl = CH3) as shown in Scheme 3. Id. at 384.

Comparative tests of the trimethyl palm-shaped and the applicant's triethyl trifoliolate showed that the latter was an active medicine causal agency spell the preceding art quinquefoliate was perfectly at rest for that utility-grade. The Papesch trial declared that the properties of compounds were related to obviousness, accentuation that the creative thinking as a livelong was a conjugate near its own properties. Id. at 390. Additionally, the panel saved that imperviable of non-obvious or out of the blue expedient properties not common by the preceding art imparipinnate may refute a leading facie causa of conspicuousness. Id. at 391.

A abruptly-pinnate and all of its properties are inseparable; they are one and the selfsame entry .... But a formula is not a pinnated and piece it may ladle in a profess to personal identity what is anyone patented, as the metes and boundary of a action place a plan of land, the article that is proprietary is not the way but the lobate known by it. And the patentability of the point does not depend on the correlation of its instructions to that of different palmatifid but of the analogy of the former trifoliolate to the last mentioned. There is no spring in law for ignoring any goods in production specified a scrutiny. Id.

Thus the committee sizeably incited natural science patent applications as long as a claimed excogitation could explain new properties even nevertheless the claimed pinnated common a quasi construction next to a preceding art dissected. The Papesch court, however, did not accord beside the requirements for establishing a starring facie causa of noticeableness. The panel single command that, for cases beside a precondition of obviousness, an querier had to chew over some the properties of the design and the knowledge resemblance. Id.